Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017 : Post-implementation Economic Evaluation
© Crown copyright 2020..
In October 2012, a maternal pertussis vaccination program was implemented in England following an increased incidence and mortality in infants. We evaluated the cost-effectiveness of the program by comparing pertussis-related infant hospitalizations and deaths in 2012-2017 with nonvaccination scenarios. Despite considerable uncertainties, findings support the cost-effectiveness of the program.
| Errataetall: |
CommentIn: Clin Infect Dis. 2020 Nov 5;71(8):1988-1989. - PMID 32095827 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 8 vom: 05. Nov., Seite 1984-1987 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sandmann, Frank [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Economic evaluation |
|---|
| Anmerkungen: |
Date Completed 27.04.2021 Date Revised 27.04.2021 published: Print CommentIn: Clin Infect Dis. 2020 Nov 5;71(8):1988-1989. - PMID 32095827 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa165 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306883856 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306883856 | ||
| 003 | DE-627 | ||
| 005 | 20231225124342.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa165 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1022.xml |
| 035 | |a (DE-627)NLM306883856 | ||
| 035 | |a (NLM)32095810 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sandmann, Frank |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017 |b Post-implementation Economic Evaluation |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.04.2021 | ||
| 500 | |a Date Revised 27.04.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Clin Infect Dis. 2020 Nov 5;71(8):1988-1989. - PMID 32095827 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Crown copyright 2020. | ||
| 520 | |a In October 2012, a maternal pertussis vaccination program was implemented in England following an increased incidence and mortality in infants. We evaluated the cost-effectiveness of the program by comparing pertussis-related infant hospitalizations and deaths in 2012-2017 with nonvaccination scenarios. Despite considerable uncertainties, findings support the cost-effectiveness of the program | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a economic evaluation | |
| 650 | 4 | |a maternal pertussis vaccination | |
| 650 | 4 | |a pertussis vaccine | |
| 650 | 4 | |a postimplementation | |
| 650 | 4 | |a whooping cough | |
| 650 | 7 | |a Pertussis Vaccine |2 NLM | |
| 700 | 1 | |a Jit, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Andrews, Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Buckley, Hannah L |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Ribeiro, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Sile, Bersabeh |e verfasserin |4 aut | |
| 700 | 1 | |a Stowe, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Tessier, Elise |e verfasserin |4 aut | |
| 700 | 1 | |a Ramsay, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Yoon H |e verfasserin |4 aut | |
| 700 | 1 | |a Amirthalingam, Gayatri |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 71(2020), 8 vom: 05. Nov., Seite 1984-1987 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2020 |g number:8 |g day:05 |g month:11 |g pages:1984-1987 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa165 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2020 |e 8 |b 05 |c 11 |h 1984-1987 | ||